Cover Image
市場調查報告書

非專利抗癌劑市場:產業趨勢、製造工程、工廠建設、機器、原料,原價&收益

Generic Oncology Drug Market - Industry Trends, Manufacturing Process, Plant Setup, Machinery, Raw Materials, Cost and Revenue

出版商 IMARC Services Pvt. Ltd. 商品編碼 354155
出版日期 內容資訊 英文 40 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
非專利抗癌劑市場:產業趨勢、製造工程、工廠建設、機器、原料,原價&收益 Generic Oncology Drug Market - Industry Trends, Manufacturing Process, Plant Setup, Machinery, Raw Materials, Cost and Revenue
出版日期: 2016年02月22日 內容資訊: 英文 40 Pages
簡介

癌症發病率的上升,受許多重量級抗癌劑的專利失效,高額的癌症治療所帶動,非專利抗癌劑市場,達成了強力的成長。

本報告提供非專利抗癌劑製造工廠計劃調查分析,建設工廠的技術、商業性藍圖,業績,製造工程必要條件,計劃的經費、資金援助、經濟性等相關驗證之系統性資訊。

第1章 調查手法

第2章 調查概要

第3章 簡介

第4章 全球學名藥市場

  • 學名藥的分類
  • 市場趨勢
  • 學名藥的價值鏈分析
  • 促進學名藥產業的主要成功因素
  • 學名藥產業的法規

第5章 全球非專利抗癌劑市場

  • 全球癌症統計
  • 現在、過去的市場趨勢
  • 主要的抗癌劑
  • 非專利抗癌劑市場的主要企業
  • 市場預測

第6章 製造工程

  • 詳細的工程 (藥丸)
  • 詳細的工程 (注射劑)
  • 非專利抗癌劑製造工廠:原料必要條件

第7章 計劃詳細內容、必要條件、經費

  • 土地、地點、基地開發
  • 工廠、機器
  • 機器照片
  • 原料
  • 包裝
  • 公共事業
  • 人力資源
  • 其他資本投資

第8章 非專利抗癌劑製造工廠:計劃的經濟性

  • 計劃的資本成本
  • 貸款、資金援助
  • 技術、經濟參數
  • 產品價格
  • 收入預測
  • 支出預測
  • 財務分析

圖表

目錄
Product Code: SRP00116BH

Driven by rising cancer incidences, patent expiry of a number of blockbuster oncology drugs and the high cost of cancer treatment, the market for generic oncology drugs has been witnessing robust growth. Apart from their strong growth, these drugs also enjoy high product differentiation and entry barriers. As a result, competitive intensity in this segment is also relatively low. This has enabled manufacturer to enjoy higher pricing power and margins compared to commoditised generics.

IMARC's latest study “Generic Oncology Drug Market - Industry Trends, Manufacturing Process, Plant Setup, Machinery, Raw Materials, Cost and Revenue” provides a comprehensive roadmap for stakeholders who are planning to setup and run a generic Oncology drug manufacturing plant. Aspects such as market size, industry trends, manufacturers, land, construction, machinery, labour, investments, revenues, rate of return, margins, etc. have been thoroughly covered in this report

Key Questions Answered in this Report?

  • What are the historical, current and future trends in the generic market?
  • What are the historical, current and future trends in the generic oncology market?
  • What is the competitive structure of the generic market and who are the key players?
  • What is the competitive structure of the generic oncology market and who are the key players?
  • What are the key success factors for generic oncology drug manufacturers?
  • How are generic oncology drugs manufactured?
  • What are the raw material requirements and their cost for manufacturing generic oncology drugs?
  • What are the land and construction requirements and their cost for manufacturing generic oncology drugs?
  • What are the machinery requirements and their cost for manufacturing generic oncology drugs?
  • What are the packaging requirements and their cost for manufacturing generic oncology drugs?
  • What are the utility requirements and their cost for manufacturing generic oncology drugs?
  • What are the manpower requirements and their cost for manufacturing generic oncology drugs?
  • What is the total capital investment required for setting up a generic oncology drug manufacturing plant
  • What are the operational costs for setting up a generic oncology drug manufacturing plant?
  • How much income will the generic oncology drug manufacturing plant generate?
  • What will be the profitability of the generic oncology drug manufacturing plant?
  • What will be the NPV of the generic oncology drug manufacturing plant?
  • What will be the payback period of the generic oncology drug manufacturing plant?

Table of Contents

1. Research Methodology

2. Report Summary

3. Introduction

4. Global Generic Drug Market

  • 4.1. Classification of Generic Drugs
  • 4.2. Market Trends
    • 4.2.1. Current and Historical Market Trends
    • 4.2.2. Market Breakup by Region
    • 4.2.3. Major Players in the Generic Drug Industry
    • 4.2.4. Market Forecast
  • 4.3. Value Chain Analysis of Generic Drugs
  • 4.4. Key Success Factors Driving the Generic Drug Industry
  • 4.6. Regulations in the Generic Drug Industry

5. Global Cancer Generics Market

  • 5.1. Global Cancer Statistics
  • 5.2. Current and Historical Market Trends
  • 5.3. Top Cancer Drugs
  • 5.4. Top Players in the Cancer Generics Market
  • 5.5. Market Forecast

6. Manufacturing Process

  • 6.1. Detailed Process Flow (Tablet)
  • 6.2. Detailed Process Flow (Injectables)
  • 6.3. Cancer Generic Manufacturing Plant: Raw Material Requirements
    • 6.3.1. Cancer Generic Drug (Tablet)
    • 6.3.2. Cancer Generic Drug (Injectables)

7. Project Details, Requirements and Costs Involved

  • 7.1. Land, Location and Site Development
  • 7.2. Plant Machinery
  • 7.3. Machinery Pictures
  • 7.4. Raw Materials
  • 7.5. Packaging
  • 7.6. Utilities
  • 7.7. Manpower
  • 7.8. Other Capital Investments

8. Cancer Generic Drug Manufacturing Plant: Project Economics

  • 8.1. Capital Cost of the Project
  • 8.2. Loans and Financial Assistance
  • 8.3. Techno-Economic Parameters
  • 8.4. Product Pricing
  • 8.5. Income Projections
  • 8.6. Expenditure Projections
  • 8.7. Financial Analysis

List of Figures

  • Figure 1-1: Global: Cancer Incidence: Breakup by Country (in %), 2015
  • Figure 4-1: Global: Generics Market: Sales Value (in US$ Billion), 2011-2015
  • Figure 4-2: Global: Generics Market: Breakup by Country (in %), 2015
  • Figure 4-3: Global: Generics Market: Sales Value (in US$ Billion), 2016-2021
  • Figure 4-4: Global: Generics Market: Value Chain
  • Figure 5-1: Global: Cancer Incidence: 2008-2015
  • Figure 5-2: Global: Cancer Incidence: Breakup by Country (in %), 2015
  • Figure 5-3: Global: Cancer Generics Market: Sales Value (in US$ Billion), 2008-2015
  • Figure 5-4: Global: Cancer Generics Market Forecast: Sales Value (in US$ Billion), 2015-2020
  • Figure 6-1: Cancer Generic (Tablet) Manufacturing: Detailed Process Flow
  • Figure 6-2: Cancer Generic (Injectable) Manufacturing: Detailed Process Flow
  • Figure 6-3: Cancer Generic (Imatinib Tablet) Manufacturing Process: Conversion Rate of Feedstocks
  • Figure 6-4: Cancer Generic (Paclitaxel) Manufacturing Process: Conversion Rate of Feedstocks
  • Figure 7-1: Cancer Generic Manufacturing Plant: Primary Packaging
  • Figure 7-2: Cancer Generic Manufacturing Plant: Secondary Packaging
  • Figure 7-3: Cancer Generic Manufacturing Plant: Tertiary Packaging
  • Figure 8-1: Cancer Generic Manufacturing Plant: Breakup of Capital Costs (in %)
  • Figure 8-2: Cancer Generic Manufacturing Plant: Breakup of Production Costs (in %)

List of Tables

  • Table 4-1: Global: Generics Market: Revenues of Key Players (in US$ Billion), 2015
  • Table 7-1: Cancer Generic Manufacturing Plant: Costs Related to Land and Site Development (in US$)
  • Table 7-2: Cancer Generic Manufacturing Plant: Costs Related to Civil Works (in US$)
  • Table 7-3: Cancer Generic Manufacturing Plant: Machinery Costs (in US$)
  • Table 7-4: Cancer Generic Manufacturing Plant: Raw Material Requirements (in Kg/Day)
  • Table 7-5: Cancer Generic Manufacturing Plant: Costs Related to Salaries and Wages (in US$)
  • Table 7-6: Cancer Generic Manufacturing Plant: Costs Related to Other Capital Investments (in US$)
  • Table 8-1: Cancer Generic Manufacturing Plant: Capital Costs (in US$)
  • Table 8-2: Details of Financial Assistance Offered by Financial Institutions
  • Table 8-3: Cancer Generic Manufacturing Plant: Loan Installments
  • Table 8-4: Cancer Generic Manufacturing Plant: Techno- Economic Parameters
  • Table 8-5: Cancer Generic Manufacturing Plant: Income Projections (in US$)
  • Table 8-6: Cancer Generic Manufacturing Plant: Expenditure Projections (in US$)
  • Table 8-7: Cancer Generic Manufacturing Plant: Cash Flow Analysis Without Considering the Income Tax Liability
  • Table 8-8: Cancer Generic Manufacturing Plant: Cash Flow Analysis on Considering the Income Tax Liability
Back to Top